There is no evidence of an association between research and development costs and prices of prescription drugs

From JAMA: “Although prices are often justified by the high cost of drug development, there is no evidence of an association between research and development costs and prices ; rather, prescription drugs are priced in the United States primarily on the basis of what the market will bear”. And I guess most pharma executives believe the market can bear a lot more. Continue reading

Pharma: Tax dodgers and price gougers?

KEY POINTS:

Continue reading

Pharma finally admits “digital is important”

KEY TAKEAWAY: GSK and Novartis have gone to the outside to hire senior digital marketing people with CPG experience.  While these moves are long overdue is it enough or is pharma waiting at the airport for their ship to come in? Continue reading